Chemotherapy of lymphoma with mechlorethamine and vinblastine.
D000328:Adult; D001772:Blood Cell Count; D001791:Blood Platelet Disorders / Q000139:chemically induced; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008223:Lymphoma / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008466:Mechlorethamine / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D014747:Vinblastine / Q000009:adverse effects / Q000627:therapeutic use*
D008466:Mechlorethamine; D014747:Vinblastine